Extensive chemotherapy for cancer treatment, particularly with human epidermal growth factor receptor 2 (HER2) inhibitors and immune checkpoint inhibitors, may cause severe cardiovascular inflammation [67,68]. This evidence concerns the gene ERBB2 and cancer.